Business

Granules charts aggressive growth story for next 3 yrs focusing on US generic biz

Granules charts aggressive growth story for next 3 yrs focusing on US generic biz Granules said it had filed 12 abbreviated new drug applications (ANDA) in FY19, and indicated about filing 20-22 ANDA filings from India and Virginia facility put together over the next two years.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts